Xavier Dolcet

12PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular targetsProcess control and simulationHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 23, 2026
miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.

Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas

|Feb 09, 2026
Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Maria Vidal-Sabanés, Raúl Navaridas, Núria Bonifaci

|Oct 06, 2025
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas

|Sep 26, 2023
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

Raúl Navaridas, Maria Vidal-Sabanés, Anna Ruiz-Mitjana

|Feb 10, 2023
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

Raúl Navaridas, Maria Vidal-Sabanés, Anna Ruiz-Mitjana

|Sep 19, 2022
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.

Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi

Pageof 2